Optiver Holding’s Avidity Biosciences RNAM Stock Holding History

Optiver Holding’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-398	Closed	-$28.7K	–	2665
2025 Q4	$28.7K	Sell	398 -279	-41%	-$18K	﹤0.01%	975
2025 Q3	$29.5K	Sell	677 -32	-5%	-$1.29K	﹤0.01%	882
2025 Q2	$20.1K	Buy	709 +335	+90%	+$9.98K	﹤0.01%	831
2025 Q1	$11K	Buy	+374	New	+$11.6K	﹤0.01%	864

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Optiver Holding's RNAM Position: Q1 2026 in Review

Optiver Holding sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 398 shares — an estimated $28.7K sold.

Optiver Holding first reported a position in RNAM in Q1 2025 and held it in 4 quarters. The position peaked at $29.5K in Q3 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Optiver Holding reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Optiver Holding sold 398 Avidity Biosciences shares in Q1 2026, an estimated $28.7K.
Optiver Holding first reported a position in Avidity Biosciences in Q1 2025 and held it in 4 quarters.
Optiver Holding's Avidity Biosciences position peaked at $29.5K in Q3 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.